Ginkgo Bioworks Holdings Q1 Sales $38.000M Miss $46.044M Estimate
Portfolio Pulse from Benzinga Newsdesk
Ginkgo Bioworks Holdings (NYSE:DNA) reported Q1 sales of $38M, missing the consensus estimate of $46.044M by 17.47%, and marking a 52.91% decrease from the same period last year.
May 09, 2024 | 8:03 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ginkgo Bioworks Holdings reported a significant miss in Q1 sales and a sharp decrease from the previous year.
Missing sales estimates by a significant margin and reporting a substantial year-over-year decline in sales are both negative indicators for a company's financial health and often lead to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100